Paul F. Lizzul, Chief Medical Officer at ANAPTYSBIO, INC (ANAB), sold 3,650 shares at $44.71 ($163K) on 2026-01-08, disclosed to the SEC on 2026-01-09.
Open-market sale of $163k ANAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2025-12-23 | $75K | — | Filing → |
| ANAB | SELL | 2024-09-24 | $58K | — | Filing → |
| ANAB | SELL | 2024-09-17 | $173K | — | Filing → |